Breaking News

Protea Offers New Bioanalytical Services

Protea Biosciences began offering bioanalytical services employing LAESI imaging mass spectrometry, a new technology for rapid and comprehensive identification of biomolecules in tissues and biofluids.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Protea Biosciences began offering bioanalytical services employing LAESI imaging mass spectrometry, a new technology for rapid and comprehensive identification of biomolecules in tissues and biofluids. LAESI-MS (Laser Ablation ElectroSpray Ionization Mass Spectrometry), enables the massively parallel identification of biomolecules found in tissues and biofluids, including metabolites, lipids, peptides, and proteins. The first LAESI-MS services will provide two- and three- dimensional imaging of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters